Skip to main content

FDA Panel Approves New Liver Drug

An FDA panel has recommended approval of a new drug aimed at treating a rare liver condition, the latest in a burgeoning field of liver-disease treatments.

Republish
Lead image for this article

An FDA panel has recommended approval of a new drug aimed at treating a rare liver condition, the latest in a burgeoning field of liver-disease treatments. The liver disease, primary biliary cirrhosis, destroys bile ducts in the liver and can lead to patients requiring liver transplants. (The Wall Street Journal)

You've read 2 articles this month. You have unlimited free articles remaining because we don't have a paywall.

Texans need truth. Help us report it.

Independent Texas reporting needs your support. The Texas Tribune delivers fact-based journalism for Texans, by Texans — and our community of members, the readers who donate, make our work possible. Help us bring you and millions of others in-depth news and information. Will you support our nonprofit newsroom with a donation of any amount?

Support independent Texas news

Become a member. Join today.

Choose an amount or learn more about membership.

$18 $20 $25 Other
Donate now

Information about the authors

Jacob Sanchez’s staff photo

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics

Read More

  • Loading recommendations for further reading
  • Loading indicatorLoading indicatorLoading indicator
  • Loading indicatorLoading indicatorLoading indicator
  • Loading indicatorLoading indicatorLoading indicator
  • Loading indicatorLoading indicatorLoading indicator